𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MACROPHAGE MEDIATED TUMOR CELL CYTOTOXICITY

✍ Scribed by Alan M. Kaplan; Page S. Morahan


Book ID
114882415
Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
631 KB
Volume
276
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Non-T-cell-mediated cytotoxicity in MSV
✍ Dr. Susanne Becker; Stephen Haskill πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 French βš– 606 KB

## Abstract Cytotoxic macrophages have been isolated Moloney sarcoma virus (MSV) tumors induced in uncompromised, immunosuppressed and athymic nude mice. Macrophages from compromised mice were least as active as those from uncompromised mice when tested against the autochthonous MSV target cells. A

Liver macrophage-mediated cytotoxicity t
✍ Carol R. Gardner; Arthur J. Wasserman; Dr. Debra L. Laskin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 895 KB

Macrophage-mediated cytotoxicity toward tumor cells usually involves extracellular lysis of the targets. In this study, we report that liver macrophages from rats treated with lipopolysaccharide (5 mg/kg, intravenous) also kill certain tumor cell targets by phagocytosis. Liver macrophages were coinc

Selective inhibition by monosaccharides
✍ Michael J. Brunda; Robert H. Wiltrout; Howard T. Holden; Luigi Varesio πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 French βš– 834 KB

## Abstract A series of monosaccharides were tested for their ability to inhibit the effector phase of macrophage‐mediated cytolysis against two susceptible murine tumor target cells, L5I78Y and RLβ™‚I. Two monosaccharides, D‐mannose and __N__‐acetyl‐D‐galactosamine, were found to decrease cytotoxici

Evaluation of the immunocompetence of ma
✍ Chou-Chik Ting; Dennis Rodrigues πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 French βš– 636 KB

## Abstract The present study has examined the competence of peritoneal cells (PC) of tumor bearers to reverse the immunosuppressive effect of tumor cells, and the ability of the tumor bearers to generate a T‐cell‐mediated cytotoxic response against allogeneic spleen cells or allogeneic tumor cells